Reports
Rates
Non-Members
Price: FREE
Science|Business Members
Price: FREE

Make sure you login to get this price.

Is your organisation a member? Check here.
If so, click here to find out how to receive your copy.
Support
Please contact us at orders@sciencebusiness.net or +32 2304 7577 if you need any assistance.
Pages: 32
Experts debate the future of stem cells

Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But how can Europe build on its leading position?

Get your free copy

  

By clicking the download button, you accept our Terms & Conditions

Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation.

But for the full advantages of cell therapy to be delivered, there must be evidence from properly regulated clinical trials of long-term benefits, allowing this new form of medicine to move from the hospital-scale, autologous model on which it operates today to a scaled-up, regulated European – and global – industry.